The biotechnology sector in the country has played a significant role in enhancing India’s global profile. India stands among the top 12 biotech destinations in the world and ranks third in the Asia Pacific, with approximately 3% share in the global biotechnology industry. The Biotechnology industry in India, comprising about 800 companies, assumes a critical role in the Indian economy. Biopharma is the largest sector contributing about 62 per cent of the total revenue followed by bio-services (18 per cent), bio-agri (15 per cent), bio-industry (4 per cent), and bio-informatics contributing (1 per cent).
By 2020, bio-incubation space of 175,000 sq. ft. has been planned with the target to support 50 world class bio-incubators. By 2025, Indian Biotechnology industry is expected to reach $100 bn.
100% FDI for biotechnology sector is allowed under the automatic route for green-field pharma.
100% FDI in biotechnology is allowed under the government route for brownfield pharma in up to 74% FDI is under automatic route and beyond 74% is under the government approval route.
Up to 100% FDI in biotechnology in India is allowed under the automatic route for the manufacturing of medical devices.
Tax deduction on R&D expenditure
Annual industrial growth
Bio-pharma revenue share
Share in Bio-services
World’s largest producer of recombinant Hepatitis B vaccine
World’s largest 2-wheeler and 3-wheeler manufacturer
World’s 3rd largest heavy truck manufacturer and 4th largest car manufacturer
FDI equity inflows into India cross $500 billion milestone
FDI India Media Coverages
PM Modi's Keynote Address at US-India Strategic Partnership Forum
Policy Watch - 100?I by NRIs in Air India
PM Modi: 'India Fulfilling Its Demands Through Make In India - FDI India